Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002320433 | SCV002607868 | uncertain significance | Inborn genetic diseases | 2020-09-14 | criteria provided, single submitter | clinical testing | The p.K1039R variant (also known as c.3116A>G), located in coding exon 15 of the ATP7A gene, results from an A to G substitution at nucleotide position 3116. The lysine at codon 1039 is replaced by arginine, an amino acid with highly similar properties. This allele was reported in one hemizygous individual in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003099210 | SCV003503709 | benign | Menkes kinky-hair syndrome; Cutis laxa, X-linked; X-linked distal spinal muscular atrophy type 3 | 2022-09-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004779289 | SCV005389269 | uncertain significance | not provided | 2024-03-18 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |